Plus   Neg

Accenture Narrows FY20 Outlook Range; Boosts Dividend 10% - Quick Facts

While reporting financial results for the third quarter on Thursday, Accenture Plc (ACN) narrowed its earnings and revenue growth guidance for the full-year 2020 and provided revenue guidance for the fourth quarter.

For fiscal 2020, the company now expects earnings in a range of $7.57 to $7.70 per share on revenue growth of 3.5 to 4.5 percent in local currency.

Previously, the company projected earnings in the range of $7.48 to $7.70 per share on revenue growth of 3 to 6 percent in local currency.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $7.58 per share on revenue growth of 2.4 percent to $44.27 billion for the year. Analysts' estimates typically exclude special items.

For the fourth quarter, Accenture expects revenues to be in the range of $10.6 billion to $11.0 billion, reflecting the company's assumption of a negative 1.0 percent foreign-exchange impact compared with the fourth quarter of fiscal 2019. The Street is looking for revenues of $10.88 billion for the quarter.

Accenture also declared a 10 percent higher quarterly cash dividend of $0.80 per share, payable on August 14, 2020 to shareholders of record at the close of business on July 16, 2020.

As previously disclosed, the company has moved from a semi-annual to a quarterly schedule for dividend payments in the first quarter of fiscal 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Billionaire Warren Buffett's Berkshire Hathaway reported a profit for the second-quarter that increased 87 percent from last year, as the value of its investment portfolio increased with the stock market. But it took about $10 billion write down on the value of its Precision Castparts aircraft parts unit due to the impact of the COVID-19 pandemic. Operating profit declined 10 percent. Twitter has had preliminary talks with TikTok's Chinese owner ByteDance to buy the U.S. operations of the video-sharing app, the Wall Street Journal reported citing people familiar with the matter. Meanwhile, Microsoft has been the only company so far to say publicly it is pursuing TikTok. Pfizer said Friday it reached a multi-year deal with Gilead Sciences to manufacture and supply Gilead's investigational antiviral remdesivir for COVID-19 patients.
Follow RTT